NCT00654446View on ClinicalTrials.gov

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

PHASE3CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

April 30, 2004

Conditions
Fredrickson Type IIa & Type IIb Dyslipidaemia
Interventions
DRUG

Rosuvastatin

DRUG

Simvastatin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00654446 - IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin | Biotech Hunter | Biotech Hunter